Schechter Investment Advisors LLC Has $1.82 Million Position in U.S. Physical Therapy, Inc. (NYSE:USPH)

Schechter Investment Advisors LLC grew its position in U.S. Physical Therapy, Inc. (NYSE:USPH) by 8.2% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 20,526 shares of the company’s stock after acquiring an additional 1,554 shares during the period. Schechter Investment Advisors LLC owned about 0.14% of U.S. Physical Therapy worth $1,821,000 at the end of the most recent quarter.

Several other institutional investors also recently modified their holdings of the company. Copeland Capital Management LLC lifted its stake in shares of U.S. Physical Therapy by 9.5% during the 4th quarter. Copeland Capital Management LLC now owns 839,356 shares of the company’s stock worth $74,459,000 after buying an additional 72,715 shares during the last quarter. State Street Corp raised its holdings in U.S. Physical Therapy by 17.5% in the 3rd quarter. State Street Corp now owns 667,868 shares of the company’s stock valued at $56,522,000 after acquiring an additional 99,244 shares during the period. Southernsun Asset Management LLC lifted its position in U.S. Physical Therapy by 10.5% during the third quarter. Southernsun Asset Management LLC now owns 547,111 shares of the company’s stock worth $46,302,000 after acquiring an additional 52,062 shares during the last quarter. Geode Capital Management LLC boosted its holdings in shares of U.S. Physical Therapy by 1.3% during the third quarter. Geode Capital Management LLC now owns 343,073 shares of the company’s stock worth $29,040,000 after acquiring an additional 4,477 shares during the period. Finally, Rockefeller Capital Management L.P. grew its position in shares of U.S. Physical Therapy by 18.8% in the third quarter. Rockefeller Capital Management L.P. now owns 160,441 shares of the company’s stock valued at $13,578,000 after purchasing an additional 25,393 shares during the last quarter.

Wall Street Analyst Weigh In

Several analysts recently issued reports on the company. William Blair restated a “market perform” rating on shares of U.S. Physical Therapy in a research note on Thursday, February 27th. JMP Securities began coverage on shares of U.S. Physical Therapy in a research report on Monday, December 16th. They set an “outperform” rating and a $113.00 price target on the stock. Citizens Jmp upgraded shares of U.S. Physical Therapy to a “strong-buy” rating in a research note on Monday, December 16th. StockNews.com lowered shares of U.S. Physical Therapy from a “hold” rating to a “sell” rating in a research report on Friday. Finally, Bank of America upgraded shares of U.S. Physical Therapy from a “neutral” rating to a “buy” rating and lifted their price target for the company from $100.00 to $115.00 in a research report on Monday, December 16th. One analyst has rated the stock with a sell rating, one has assigned a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $111.50.

Insiders Place Their Bets

In other news, CFO Carey P. Hendrickson sold 516 shares of U.S. Physical Therapy stock in a transaction dated Monday, December 9th. The stock was sold at an average price of $96.25, for a total transaction of $49,665.00. Following the sale, the chief financial officer now directly owns 20,469 shares of the company’s stock, valued at approximately $1,970,141.25. This trade represents a 2.46 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Insiders own 1.70% of the company’s stock.

U.S. Physical Therapy Trading Down 2.1 %

Shares of U.S. Physical Therapy stock opened at $79.31 on Tuesday. The firm’s 50-day moving average price is $88.20 and its two-hundred day moving average price is $87.65. The company has a market capitalization of $1.20 billion, a price-to-earnings ratio of 84.37, a PEG ratio of 3.54 and a beta of 1.48. The company has a quick ratio of 1.78, a current ratio of 1.78 and a debt-to-equity ratio of 0.27. U.S. Physical Therapy, Inc. has a 12-month low of $76.18 and a 12-month high of $113.63.

U.S. Physical Therapy (NYSE:USPH) last posted its quarterly earnings results on Wednesday, February 26th. The company reported $0.65 EPS for the quarter, missing analysts’ consensus estimates of $0.69 by ($0.04). The business had revenue of $180.45 million for the quarter, compared to analyst estimates of $173.10 million. U.S. Physical Therapy had a return on equity of 8.11% and a net margin of 3.54%. On average, analysts forecast that U.S. Physical Therapy, Inc. will post 2.67 earnings per share for the current fiscal year.

U.S. Physical Therapy Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, April 11th. Shareholders of record on Friday, March 14th will be given a $0.45 dividend. The ex-dividend date of this dividend is Friday, March 14th. This represents a $1.80 dividend on an annualized basis and a yield of 2.27%. This is a positive change from U.S. Physical Therapy’s previous quarterly dividend of $0.44. U.S. Physical Therapy’s dividend payout ratio (DPR) is currently 97.83%.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.